Mukka’s Protein Push Hits Pause: FABBCO Deal Faces Execution Delay

Mukka Proteins Ltd’s strategic acquisition of a 51% stake in FABBCO Bio Cycle and Bio Protein Technology Pvt Ltd has encountered a delay in execution, despite initial plans to close the deal by June 30, 2025. The ₹6 crore investment was aimed at bolstering Mukka’s alternative protein portfolio, particularly in insect-based feed solutions, a fast-growing segment in sustainable aquaculture and livestock nutrition.

 

The delay, while not officially attributed to specific regulatory or operational hurdles, is believed to stem from pending closing conditions and procedural clearances. Mukka has yet to issue a revised timeline, but sources suggest the transaction remains on track for completion in the near term.

 

FABBCO specializes in insect meal production and organic waste processing, aligning with Mukka’s broader vision of reducing reliance on traditional fishmeal and promoting circular economy principles. The acquisition was expected to complement Mukka’s existing venture, Ento Proteins, and position the company as a leader in environmentally responsible feed solutions.

 

Despite the delay, investor sentiment remains cautiously optimistic. Mukka’s stock had earlier surged nearly 3% following the acquisition announcement in March 2025, reflecting market confidence in the company’s diversification strategy.

 

As Mukka navigates the final leg of this acquisition, the industry will be watching closely—both for the deal’s closure and its potential to reshape India’s sustainable protein landscape.

 

Sources: Business Standard, BSE India, The Hindu BusinessLine